Related Experiment Video
Updated: Aug 18, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
[Growth Hormone (GH) treatment in GH deficient children]
1Division of Endocrinology and Metabolism, National Center for Child Health and Development.
Clinical Calcium
|March 19, 2005
Abstract:
Bone mineral density (BMD) is reduced in children with growth hormone deficiency. Long-term GH therapy has been shown to increase BMD and levels of biochemical markers of bone turnovre. Adequate GH replacement therapy should be performed, starting as early as possible and optimizing treatment with adequate dose to achieve normal BMD at the time of reaching final height.
Related Concept Videos
01:10Nature and Nurture
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...